- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.2B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.2B |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $1.14B |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $1.18B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $506.6M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $467.8M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.85B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.79B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $3.04B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.03B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $9.53B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $9.36B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $488.1M |
| Cash And Equivalents restated | Q1 2025 · Mar 31, 2024 | $433.3M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 28.54M sh |
| Stock Repurchased restated | Q1 2025 · Mar 31, 2024 | $4.7M |
| Capex restated | Q1 2025 · Mar 31, 2024 | $40.2M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $69.8M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $9.05B |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $8.74B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $13.45 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $13.46 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $214.9M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $66.4M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | $383.9M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $44.6M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $325.9M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $284.9M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $610.8M |